Dear Colleague,

We hope you will take 10-15 minutes to answer this brief survey about medical treatment in childhood epilepsy from ILAE’s Paediatric Commission Medical Task Force.

The aim of the survey is to study your current treatment practices in 6 typical early life epilepsy scenarios. Our aim is not only to show first and second line treatment preferences, but also to illustrate that we commonly use off-label drugs in childhood epilepsies.

Please answer the questions referring to your daily clinical practice (and not what you know from textbooks, guidelines etc). We start with some questions about your current situation followed by the 6 scenarios. For the anti-seizure drugs, please use their generic name and not a  brand name. Please complete the survey only once, as it is possible that you will receive this survey through different channels.

All your personal data will remain anonymized of course.

We would appreciate receiving your responses before October 1!

Thank you for your collaboration!

Lieven Lagae

On behalf of the ILAE Medical Task force:

Alexis Arzimanoglou, Stéphane Auvin, Helen Cross, Hans Hartmann, Ronit Pressler, Kate Riney, Kenji Sugai,  Jo Wilmshurst , Elissa Yozawitz

T